This article has been cited by other articles in PMC.
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (734K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
These references are in PubMed. This may not be the complete list of references from this article.
Studd J, Savvas M, Waston N, Garnett T, Fogelman I, Cooper D. The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants. Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1474–1479.[PubMed]
Ross RK, Paganini-Hill A, Mack TM, Arthur M, Henderson BE. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet. 1981 Apr 18;1(8225):858–860.[PubMed]
Montgomery JC, Appleby L, Brincat M, Versi E, Tapp A, Fenwick PB, Studd JW. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet. 1987 Feb 7;1(8528):297–299.[PubMed]
Wilkes HC, Meade TW. Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework. BMJ. 1991 Jun 1;302(6788):1317–1320.[PMC free article][PubMed]
Brinton LA, Hoover RN, Szklo M, Fraumeni JF., Jr Menopausal estrogen use and risk of breast cancer. Cancer. 1981 May 15;47(10):2517–2522.[PubMed]
Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med. 1989 Aug 3;321(5):293–297.[PubMed]
Bergkvist L, Adami HO, Persson I, Bergström R, Krusemo UB. Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol. 1989 Aug;130(2):221–228.[PubMed]
Sturdee DW, Wade-Evans T, Paterson ME, Thom M, Studd JW. Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal women. Br Med J. 1978 Jun 17;1(6127):1575–1577.[PMC free article][PubMed]
Paterson ME, Wade-Evans T, Sturdee DW, Thom MH, Studd JW. Endometrial disease after treatment with oestrogens and progestogens in the climacteric. Br Med J. 1980 Mar 22;280(6217):822–824.[PMC free article][PubMed]
Magos AL, Brewster E, Singh R, O'Dowd T, Brincat M, Studd JW. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol. 1986 Dec;93(12):1290–1296.[PubMed]
Magos AL, Brincat M, Studd JW, Wardle P, Schlesinger P, O'Dowd T. Amenorrhea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women. Obstet Gynecol. 1985 Apr;65(4):496–499.[PubMed]
Leather AT, Savvas M, Studd JW. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women. Obstet Gynecol. 1991 Dec;78(6):1008–1010.[PubMed]
Hunt K, Vessey M, McPherson K, Coleman M. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol. 1987 Jul;94(7):620–635.[PubMed]
Garnett T, Studd JW, Henderson A, Watson N, Savvas M, Leather A. Hormone implants and tachyphylaxis. Br J Obstet Gynaecol. 1990 Oct;97(10):917–921.[PubMed]
Bewley S, Bewley TH. Drug dependence with oestrogen replacement therapy. Lancet. 1992 Feb 1;339(8788):290–291.[PubMed]
Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press